AnnouncementDetails

Actions

National Medical Care Co. announces to Invites its Shareholders to Attend the ( First Meeting ) Ordinary General Assembly Meeting through the modern technology means

Element ListExplanation
Introduction The Board of Directors of the National Medical Care Company is pleased to invite its valued shareholders to attend the Ordinary General Assembly meeting, in the city of Riyadh at the company’s headquarters
City and Location of the General Assembly's Meeting The company's headquarter in Riyadh, by means of modern technology
URL for the Meeting Location https://www.tadawulaty.com.sa
Date of the General Assembly's Meeting 2022-09-06 Corresponding to 1444-02-10
Time of the General Assembly's Meeting 18:30
Attendance Eligibility Shareholders Registered in the Issuer’s Shareholders Registry in the Depository Centre At the End of the Trading Session Preceding the General Assembly’s Meeting as per Laws and Regulations
Quorum for Convening the General Assembly's Meeting In accordance with Article 33 of the Company's bylaws, the meeting shall be attended by shareholders representing at least 50% of the share capital. If the quorum is not completed at this meeting, a second meeting shall be held one hour after the scheduled time for the first meeting. The second meeting shall be valid regardless of the number of shares represented in it.
General Assembly Meeting Agenda 1. To Vote for the election of members of the Board of Directors from among the candidates for the next session, which starts on 15-09-2022 and ends on 14-09-2025 for a period of three years. (Attached CV for candidates)

2. To Vote on the formation of the Audit Committee and define its tasks, work controls and remuneration for its members for the new session starting from 15-09-2022 until the end of the session on 14-09-2025, noting that the candidates (attached with their CVs) are:

1- Sami Suliman AlKashan (independent member)

2-Bashar Abdulaziz Abalkail(independent member)

3-Faraj saad Al-Gabani (non-executive member)

3. To Vote on delegating the Board of Directors for its session starting from 15-09-2022 AD with validity to the authority of the Ordinary General Assembly with the authorization contained in Paragraph (1) of Article 71 of the Companies Law, for a period of one year from the date of approval of the General Assembly or until the end of the delegated Board of Directors session, whichever is earlier, in accordance with the conditions set forth in The controls and regulatory procedures issued in implementation of the Companies Law for Listed Joint Stock Companies.

Proxy Form
E-Vote That the valued shareholders registered in the Tadawulaty services can vote remotely on the items on the assembly’s agenda starting from ten in the morning on Friday 06/02/1444 corresponding to September 06, 2022 until the end of the time of the extraordinary general assembly, bearing in mind that registration and voting in Tadawulaty services It is available free of charge to all contributors using the following link:

www.tadawulaty.com.sa

Eligibility for Attendance Registration and Voting Eligibility for Registering the Attendance of the General Assembly’s Meeting Ends upon the Convenience of the General Assembly’s Meeting. Eligibility for Voting on the Business of the Meeting Agenda Ends upon the Counting Committee Concludes Counting the Votes
Method of Communication In case of inquiries, we hope to communicate with shareholders' relations management (Tel: 0114931881) or email: (Care.ir@care.med.sa)
Attached Documents     

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Profile

Actions

Company Profile

Summary

Last Price Net Change
72.3 0.8 (+1.12%)
Value Traded (SAR) Volume Traded
965,252.5 13,456